주식/증권
📉 부정적
Hims Insider Makes First Stock Purchase Since 2021 Amid Weight-Loss Drug Pivot
요약
Hims & Hers Health shares have slumped in 2026 as the telehealth provider moves away from selling compounded GLP-1 medications.